INVESTORS.TOKAIPHARMACEUTICALS.COM HOST
Our parsers revealed that a lone root page on investors.tokaipharmaceuticals.com took eight hundred and twenty-eight milliseconds to come up. We could not detect a SSL certificate, so therefore our web crawlers consider investors.tokaipharmaceuticals.com not secure.
Internet Protocol
184.25.56.203
PAGE TITLE
Tokai Nasdaq Investors Media OverviewDESCRIPTION
160; 0.02. Data provided by Nasdaq. Minimum 15 minutes delayed. Tokai Pharmaceuticals and Otic Pharma Enter into Share Purchase Agreement. Tokai Pharmaceuticals Announces Review of Strategic Alternatives. Tokai Pharmaceuticals Announces Reduction in Force. BOSTON- BUSINESS WIRE- Jul. 29, 2016- Tokai Pharmaceuticals Inc. NASDAQ TKAI, a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announ.Tokai.CONTENT
This web page states the following, "Tokai Pharmaceuticals and Otic Pharma Enter into Share Purchase Agreement." We saw that the web site stated " Tokai Pharmaceuticals Announces Review of Strategic Alternatives." It also said " Tokai Pharmaceuticals Announces Reduction in Force. 29, 2016- Tokai Pharmaceuticals Inc. NASDAQ TKAI, a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announ."